Cite
HARVARD Citation
Lipton, J. et al. (n.d.). Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial. Lancet oncology. 17 (5), pp. 612-621. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lipton, J. et al. (n.d.). Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial. Lancet oncology. 17 (5), pp. 612-621. [Online].